Boston Scientific announced an analysis of 989 patients with hepatocellular carcinoma (HCC) from the PROACTIF prospective ...

InVera Medical announced 12-month results from its pilot clinical study of the InVera infusion device for the treatment of ...

Efemoral Medical announced long-term results of the first 40 patients treated in the EFEMORAL I first-in-human (FIH) clinical ...

In this retrospective analysis, Zil-E-Ali et al found that patients with government-funded insurance who underwent urgent or ...

Gore & Associates announced new 12-month findings from the global GORE VIABAHN FORTEGRA Venous Stent IVC trial, which evaluat ...

Sonorous Neurovascular, a developer of solutions for cerebral venous diseases and neurovascular interventions, announced that ...

Gore & Associates announced that its Excluder thoracoabdominal branch endoprosthesis (TAMBE) received CE Mark approval earlie ...

Stryker announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), which is a private ...

VIRad.AI announced the launch of its artificial intelligence (AI)–powered clinical decision support platform, designed spec ...

RenovoRx, Inc., which is developing targeted oncology therapies and commercializing its FDA-cleared RenovoCath drug-delivery devi ...

Cook Medical and Siemens Healthineers introduced their integrated interventional MRI (iMRI) suite at SIR 2026, the Society of ...

The Society of Interventional Radiology (SIR) announced results from the C-TRACT study, which is investigating the treatment ...